Citigroup Inc Eli Lilly & CO Put Options Transaction History

Citigroup Inc

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $46.2 Million - $57.4 Million	59,800 Added 35.62%	227,700 $202 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $26 Million - $32.6 Million	-35,900 Reduced 17.62%	167,900 $152 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $23 Million - $30.7 Million	-38,800 Reduced 15.99%	203,800 $159 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $25.5 Million - $30 Million	48,500 Added 24.99%	242,600 $141 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $17.5 Million - $24.2 Million	-40,300 Reduced 17.19%	194,100 $104 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $20.4 Million - $27.3 Million	58,200 Added 33.03%	234,400 $110 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $21.7 Million - $25.5 Million	-69,900 Reduced 28.4%	176,200 $60.5 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $9.74 Million - $11.4 Million	30,300 Added 14.04%	246,100 $90 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $27.2 Million - $31 Million	91,800 Added 74.03%	215,800 $69.8 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $14.3 Million - $16.8 Million	51,300 Added 70.56%	124,000 $40.2 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $15.1 Million - $18.8 Million	-64,300 Reduced 46.93%	72,700 $20.8 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $2.79 Million - $3.46 Million	12,400 Added 9.95%	137,000 $37.8 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $27.6 Million - $34 Million	124,600 New	124,600 $28.8 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.